NDC00004-1956-01: SULFAMETHOXAZOLE AND TRIMETHOPRI.
SULFAMETHOXAZOLE AND TRIMETHOPRI. Key specifications include administration: INTRAVENOUS INFUSION, special_features: FLIP-CAP VIAL, features_provided: STERILE, primary_container_type: VIAL, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 10. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-143-3750, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | INTRAVENOUS INFUSION |
| special_features | FLIP-CAP VIAL |
| features_provided | STERILE |
| primary_container_type | VIAL |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 10 |
| primary_container_content_quantity | 5.000 MILLILITERS |
| active_medicament_medicinal_strength | 80.000 MILLIGRAMS SULFAMETHOXAZOLE ACTIVE INGREDIENT AND 16.000 MILLIGRAMS TRIMETHOPRIM ACTIVE INGREDIENT |
| NSN | 6505-01-143-3750 |
| ADMINISTRATION | INTRAVENOUS INFUSION |
| PRIMARY CONTAINER CONTENT QUANTITY | 5.000 MILLILITERS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| FEATURES PROVIDED | STERILE |
| PRIMARY CONTAINER TYPE | VIAL |
| SPECIAL FEATURES | FLIP-CAP VIAL |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 80.000 MILLIGRAMS SULFAMETHOXAZOLE ACTIVE INGREDIENT AND 16.000 MILLIGRAMS TRIMETHOPRIM ACTIVE INGREDIENT |
| TOTAL PRIMARY CONTAINER QUANTITY | 10 |